Dr. N.Kumarasamy is a clinician and a researcher in infectious diseases with more than 20 years’ experience in the field of HIV medicine. He is the Chief Medical Officer at YRGCARE, and directs the clinic which provides medical care for more than 22,000 people with HIV in Chennai, southern India. He is the Chief and Site Leader of the Chennai Antiviral Research and Treatment clinical research site (CART) of the US National Institutes of Health, which conduct multisite clinical trials on therapeutics (ACTG)and prevention (HPTN). He is also involved as Clinical Investigator in several on-going clinical research projects with the University of California- San Diego, Harvard University- Boston,Brown University-Providence and Kirby Institute,Univ. New South Wales- Sydney.
Dr. Kumarasamy studied Medicine at Madras Medical College, underwent specialized training and a fellowship in Infectious Diseases and HIV Medicine at Brown University and John Hopkins University in the USA, and his PhD in Infectious Diseases at the University of Madras. He is an expert panel member for the WHO ARV treatment guidelines committee, a clinical advisor to the Clinton Health Access Initiative, and has published more than 350 manuscripts in peer reviewed medical journals. His publications on the impact of generic antiretroviral therapy have led to several antiretroviral scale-up programs in developing countries: he has a particular interest in the long term impact of antiretroviral therapy in resource limited settings.